PULM
Price
$5.32
Change
-$0.64 (-10.74%)
Updated
Apr 4, 04:36 PM (EDT)
Capitalization
21.77M
35 days until earnings call
TSHA
Price
$1.22
Change
-$0.04 (-3.17%)
Updated
Apr 4, 02:54 PM (EDT)
Capitalization
260.35M
33 days until earnings call
Ad is loading...

PULM vs TSHA

Header iconPULM vs TSHA Comparison
Open Charts PULM vs TSHABanner chart's image
Pulmatrix
Price$5.32
Change-$0.64 (-10.74%)
Volume$130
Capitalization21.77M
Taysha Gene Therapies
Price$1.22
Change-$0.04 (-3.17%)
Volume$9.84K
Capitalization260.35M
PULM vs TSHA Comparison Chart
Loading...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PULM vs. TSHA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PULM is a Hold and TSHA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (PULM: $5.96 vs. TSHA: $1.26)
Brand notoriety: PULM and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PULM: 57% vs. TSHA: 129%
Market capitalization -- PULM: $21.77M vs. TSHA: $260.35M
PULM [@Biotechnology] is valued at $21.77M. TSHA’s [@Biotechnology] market capitalization is $260.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PULM’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • PULM’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, PULM is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PULM’s TA Score shows that 2 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • PULM’s TA Score: 2 bullish, 6 bearish.
  • TSHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than PULM.

Price Growth

PULM (@Biotechnology) experienced а -17.45% price change this week, while TSHA (@Biotechnology) price change was -32.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.84%. For the same industry, the average monthly price growth was -16.73%, and the average quarterly price growth was -18.28%.

Reported Earning Dates

PULM is expected to report earnings on May 09, 2025.

TSHA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-10.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($260M) has a higher market cap than PULM($21.8M). PULM YTD gains are higher at: -14.613 vs. TSHA (-27.168). PULM has higher annual earnings (EBITDA): -6.78M vs. TSHA (-87.95M). TSHA has more cash in the bank: 139M vs. PULM (10.8M). PULM has less debt than TSHA: PULM (0) vs TSHA (63.2M). PULM has higher revenues than TSHA: PULM (10M) vs TSHA (8.33M).
PULMTSHAPULM / TSHA
Capitalization21.8M260M8%
EBITDA-6.78M-87.95M8%
Gain YTD-14.613-27.16854%
P/E RatioN/A2.70-
Revenue10M8.33M120%
Total Cash10.8M139M8%
Total Debt063.2M-
FUNDAMENTALS RATINGS
PULM: Fundamental Ratings
PULM
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PULMTSHA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
71%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUEUX34.45N/A
N/A
MFS Blended Research Core Equity R4
SGHIX10.94N/A
N/A
Saturna Global High Income
MSEPX20.38N/A
N/A
Morgan Stanley Inst Emerging Mkts C
DMCFX25.65N/A
N/A
Invesco Discovery Mid Cap Growth R5
JNVYX18.36N/A
N/A
Jensen Quality Mid Cap Y

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-4.55%
LOGC - TSHA
45%
Loosely correlated
-3.50%
ALT - TSHA
37%
Loosely correlated
-6.69%
ARWR - TSHA
35%
Loosely correlated
-4.96%
TRDA - TSHA
35%
Loosely correlated
-8.86%
DNTH - TSHA
35%
Loosely correlated
-4.98%
More